The clinical development of sGC modulators, riociguat and vericiguat

von Misselwitz, Frank
Veröffentlicht in BMC Pharmacol Toxicol (2015)

Evidence-Based Development and Rationale for Once-Daily Rivaroxaban Dosing Regimens Across Multiple Indications

von Kubitza, Dagmar, Berkowitz, Scott D., Misselwitz, Frank
Veröffentlicht in Clin Appl Thromb Hemost (2016)

Impact of gender on event rates at 1 year in patients with newly diagnosed non-valvular atrial fibrillation: contemporary perspective from the GARFIELD-AF registry

von Camm, A John, Accetta, Gabriele, Al Mahmeed, Wael, Ambrosio, Giuseppe, Goldhaber, Samuel Z, Haas, Sylvia, Jansky, Petr, Kayani, Gloria, Misselwitz, Frank, Oh, Seil, Oto, Ali, Raatikainen, Pekka, Steffel, Jan, van Eickels, Martin, Kakkar, Ajay K
Veröffentlicht in BMJ Open (2017)

The association between patterns of atrial fibrillation, anticoagulation, and cardiovascular events

von Atar, Dan, Berge, Eivind, Le Heuzey, Jean-Yves, Virdone, Saverio, Camm, A John, Steffel, Jan, Gibbs, Harry, Goldhaber, Samuel Z, Goto, Shinya, Kayani, Gloria, Misselwitz, Frank, Stepinska, Janina, Turpie, Alexander G G, Bassand, Jean-Pierre, Kakkar, Ajay K
Veröffentlicht in Europace (2020)

Peri-procedural use of rivaroxaban in elective percutaneous coronary intervention to treat stable coronary artery disease: The X-PLORER trial

von Vranckx, Pascal, Leebeek, Frank W. G., Tijssen, Jan G. P., Koolen, Jacques, Stammen, Francis, Herman, Jean-Paul R., de Winter, Robbert J., van t Hof, Arnout W. J., Backx, Bianca, Lindeboom, Wietze, Kim, So-Young, Kirsch, Bodo, van Eickels, Martin, Misselwitz, Frank, Verheugt, Freek W. A.
Veröffentlicht in Thromb Haemost (2015)

New artificial intelligence prediction model using serial prothrombin time international normalized ratio measurements in atrial fibrillation patients on vitamin K antagonists: GAR...

von Goto, Shinichi, Goto, Shinya, Pieper, Karen S, Bassand, Jean-Pierre, Camm, Alan John, Fitzmaurice, David A, Goldhaber, Samuel Z, Haas, Sylvia, Parkhomenko, Alexander, Oto, Ali, Misselwitz, Frank, Turpie, Alexander G G, Verheugt, Freek W A, Fox, Keith A A, Gersh, Bernard J, Kakkar, Ajay K
Veröffentlicht in Eur Heart J Cardiovasc Pharmacother (2019)

Bleeding and related mortality with NOACs and VKAs in newly diagnosed atrial fibrillation: results from the GARFIELD-AF registry

von Bassand, Jean-Pierre, Virdone, Saverio, Badoz, Marc, Verheugt, Freek W. A., Camm, A. John, Cools, Frank, Fox, Keith A. A., Goldhaber, Samuel Z., Goto, Shinya, Haas, Sylvia, Hacke, Werner, Kayani, Gloria, Misselwitz, Frank, Pieper, Karen S., Turpie, Alexander G. G., van Eickels, Martin, Kakkar, Ajay K.
Veröffentlicht in Blood Adv (2021)

Risk Profiles and Antithrombotic Treatment of Patients Newly Diagnosed with Atrial Fibrillation at Risk of Stroke: Perspectives from the International, Observational, Prospective G...

von Kakkar, Ajay K., Mueller, Iris, Bassand, Jean-Pierre, Fitzmaurice, David A., Goldhaber, Samuel Z., Goto, Shinya, Haas, Sylvia, Hacke, Werner, Lip, Gregory Y. H., Mantovani, Lorenzo G., Turpie, Alexander G. G., van Eickels, Martin, Misselwitz, Frank, Rushton-Smith, Sophie, Kayani, Gloria, Wilkinson, Peter, Verheugt, Freek W. A.
Veröffentlicht 2013

Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF

von Bassand, Jean-Pierre, Accetta, Gabriele, Camm, Alan John, Cools, Frank, Fitzmaurice, David A., Fox, Keith A.A., Goldhaber, Samuel Z., Goto, Shinya, Haas, Sylvia, Hacke, Werner, Kayani, Gloria, Mantovani, Lorenzo G., Misselwitz, Frank, ten Cate, Hugo, Turpie, Alexander G.G., Verheugt, Freek W.A., Kakkar, Ajay K.
Veröffentlicht in Eur Heart J (2016)

Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation: A Report From the GARFIELD-AF Registry

von Corbalan, Ramon, Bassand, Jean-Pierre, Illingworth, Laura, Ambrosio, Giuseppe, Camm, A. John, Fitzmaurice, David A., Fox, Keith A. A., Goldhaber, Samuel Z., Goto, Shinya, Haas, Sylvia, Kayani, Gloria, Mantovani, Lorenzo G., Misselwitz, Frank, Pieper, Karen S., Turpie, Alexander G. G., Verheugt, Freek W. A., Kakkar, Ajay K.
Veröffentlicht in JAMA Cardiol (2019)

Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial Fibrillation

von Fox, Keith A. A., Velentgas, Priscilla, Camm, A. John, Bassand, Jean-Pierre, Fitzmaurice, David A., Gersh, Bernard J., Goldhaber, Samuel Z., Goto, Shinya, Haas, Sylvia, Misselwitz, Frank, Pieper, Karen S., Turpie, Alexander G. G., Verheugt, Freek W. A., Dabrowski, Elizabeth, Luo, Kaiyi, Gibbs, Liza, Kakkar, Ajay K.
Veröffentlicht in JAMA Netw Open (2020)

Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation

von Camm, A John, Accetta, Gabriele, Ambrosio, Giuseppe, Atar, Dan, Bassand, Jean-Pierre, Berge, Eivind, Cools, Frank, Fitzmaurice, David A, Goldhaber, Samuel Z, Goto, Shinya, Haas, Sylvia, Kayani, Gloria, Koretsune, Yukihiro, Mantovani, Lorenzo G, Misselwitz, Frank, Oh, Seil, Turpie, Alexander G G, Verheugt, Freek W A, Kakkar, Ajay K
Veröffentlicht in Heart (2017)

Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without ant...

von Fox, Keith A A, Lucas, Joseph E, Pieper, Karen S, Bassand, Jean-Pierre, Camm, A John, Fitzmaurice, David A, Goldhaber, Samuel Z, Goto, Shinya, Haas, Sylvia, Hacke, Werner, Kayani, Gloria, Oto, Ali, Mantovani, Lorenzo G, Misselwitz, Frank, Piccini, Jonathan P, Turpie, Alexander G G, Verheugt, Freek W A, Kakkar, Ajay K
Veröffentlicht in BMJ Open (2017)

Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry

von Haas, Sylvia, ten Cate, Hugo, Accetta, Gabriele, Angchaisuksiri, Pantep, Bassand, Jean-Pierre, Camm, A. John, Corbalan, Ramon, Darius, Harald, Fitzmaurice, David A., Goldhaber, Samuel Z., Goto, Shinya, Jacobson, Barry, Kayani, Gloria, Mantovani, Lorenzo G., Misselwitz, Frank, Pieper, Karen, Schellong, Sebastian M., Stepinska, Janina, Turpie, Alexander G. G., van Eickels, Martin, Kakkar, Ajay K.
Veröffentlicht in PLoS One (2016)

Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions

von Gheorghiade, Mihai, Vaduganathan, Muthiah, Greene, Stephen J., Mentz, Robert J., Adams, Kirkwood F., Anker, Stefan D., Arnold, Malcolm, Baschiera, Fabio, Cleland, John G. F., Cotter, Gadi, Fonarow, Gregg C., Giordano, Christopher, Metra, Marco, Misselwitz, Frank, Mühlhofer, Eva, Nodari, Savina, Peacock, W. Frank, Pieske, Burkert M., Sabbah, Hani N., Sato, Naoki, Shah, Monica R., Stockbridge, Norman L., Teerlink, John R., van Veldhuisen, Dirk J., Zalewski, Andrew, Zannad, Faiez, Butler, Javed
Veröffentlicht 2014

Developing Therapies for Heart Failure with Preserved Ejection Fraction: Current State and Future Directions

von Butler, Javed, Fonarow, Gregg C., Zile, Michael R., Lam, Carolyn S., Roessig, Lothar, Schelbert, Erik B., Shah, Sanjiv J., Ahmed, Ali, Bonow, Robert O., Cleland, John GF, Cody, Robert J., Chioncel, Ovidiu, Collins, Sean P., Dunnmon, Preston, Filippatos, Gerasimos, Lefkowitz, Martin P., Marti, Catherine N., McMurray, John J., Misselwitz, Frank, Nodari, Savina, O’Connor, Christopher, Pfeffer, Marc A., Pieske, Burkert, Pitt, Bertram, Rosano, Guiseppe, Sabbah, Hani N., Senni, Michele, Solomon, Scott D., Stockbridge, Norman, Teerlink, John R., Georgiopoulou, Vasiliki V., Gheorghiade, Mihai
Veröffentlicht 2014